← Scroll for more →
Cytek Biosciences, Inc. (CTKB)
Laboratory Analytical Instruments
Latest Price
$5.96
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
2.49
P/B Ratio
2.39
Valuation metrics
adjust assumptions →Base FCF: $633,000 (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$1.07
82% downside
Institutional Ownership
61.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.58M | $42.0M | 7.37% | -7.43M | 2026-06-30 |
| Millennium Management LLC | 9.34M | $41.0M | 7.18% | +3.05M | 2026-06-30 |
| Boston Partners | 7.66M | $33.0M | 5.89% | +1.86M | 2026-06-30 |
| Hhlr Advisors, Ltd. | 6.66M | $29.0M | 5.12% | -- | 2026-06-30 |
| Topline Capital Management, LLC | 6.28M | $27.0M | 4.83% | -781.0K | 2026-06-30 |
| Vanguard Capital Management LLC | 4.94M | $21.0M | 3.80% | +176.7K | 2026-06-30 |
| Geode Capital Management, LLC | 3.06M | $13.0M | 2.35% | +225.6K | 2026-06-30 |
| Dimensional Fund Advisors LP | 2.62M | $11.0M | 2.01% | -47.1K | 2026-06-30 |
| State Street Corp | 2.57M | $11.0M | 1.97% | -1.56M | 2026-06-30 |
| Goldman Sachs Group Inc | 2.17M | $9.0M | 1.67% | -177.2K | 2026-06-30 |